Updated: January 13, 2026
Molnupiravir Drug Interactions: What to Avoid and What to Tell Your Doctor

- Does Molnupiravir Have Any Drug Interactions?
- Why Molnupiravir's Lack of Interactions Matters Clinically
- What About Alcohol and Molnupiravir?
- What About Food Interactions?
- The Key Precaution: Pregnancy and Reproductive Safety
- Should You Still Tell Your Doctor All Your Medications?
- Molnupiravir vs. Paxlovid: Why the Interaction Profile Matters
Overview
Good news: molnupiravir (Lagevrio) has no known drug-drug interactions. But there are still important precautions patients should understand before taking it.
Is Molnupiravir in stock near you?
Based on 60 real pharmacy checks · 1 patients helped
Verified 5h ago
When comparing COVID-19 antivirals, drug interactions are one of the most important factors. Paxlovid (nirmatrelvir/ritonavir) has dozens of clinically significant drug-drug interactions — with blood thinners, statins, immunosuppressants, seizure medications, and many others. This makes it unusable for a significant portion of high-risk patients.
Molnupiravir (Lagevrio) has a major advantage here: as of 2026, no clinically significant drug-drug interactions have been identified. But this doesn't mean there are zero precautions to take. Here's everything you need to know.
Does Molnupiravir Have Any Drug Interactions?
According to the FDA EUA Fact Sheet, the NIH COVID-19 Treatment Guidelines, and the current molnupiravir prescribing information: no drug-drug interactions have been identified for molnupiravir. Multiple independent drug reference sources — including Medscape, RxList, WebMD, and the Liverpool COVID Drug Interactions database — confirm that molnupiravir has no known severe, serious, or moderate drug-drug interactions.
This is because molnupiravir is not metabolized by the same CYP450 liver enzyme pathways that cause the extensive Paxlovid interaction profile. Molnupiravir is primarily cleared through metabolism to uridine and cytidine — which are normal nucleotides that mix into the body's existing nucleotide pools — and through renal and hepatic clearance.
Check live stock now.
Why Molnupiravir's Lack of Interactions Matters Clinically
For patients who need COVID-19 antiviral treatment but cannot take Paxlovid due to drug interactions, molnupiravir is often the only viable oral alternative. This patient population includes people taking:
Blood thinners like warfarin or apixaban (Eliquis)
Statins (some cannot be temporarily held, or holding them poses risk)
Immunosuppressants like tacrolimus, cyclosporine, or mycophenolate (transplant patients)
HIV medications (certain antiretrovirals)
Seizure medications (carbamazepine, phenytoin, phenobarbital)
Psychiatric medications that interact with CYP3A4
For all these patients, molnupiravir can be prescribed without the need to adjust, hold, or monitor for interactions with their existing medications.
What About Alcohol and Molnupiravir?
There is no known pharmacological interaction between alcohol and molnupiravir. However, heavy alcohol use is not recommended while you're fighting a COVID-19 infection because:
Alcohol can suppress immune function and slow your body's ability to fight infection.
Dizziness is a known side effect of molnupiravir; alcohol can worsen dizziness.
Alcohol can cause dehydration, which makes COVID-19 symptoms worse.
What About Food Interactions?
No food-drug interactions have been identified for molnupiravir. Food affects the rate (how quickly) of absorption but not the extent (how much is absorbed). This means you can take molnupiravir with or without food. If you experience nausea, taking it with food may help reduce stomach discomfort.
The Key Precaution: Pregnancy and Reproductive Safety
While molnupiravir has no drug-drug interactions, it does carry a significant reproductive safety warning:
Pregnancy: Molnupiravir is NOT recommended in pregnancy. Animal studies showed embryo-fetal lethality and birth defects. A boxed warning is included in the prescribing information.
Females of childbearing potential: Use reliable contraception during treatment and for 4 days after the last dose.
Males with female partners who could become pregnant: Use reliable contraception during treatment and for at least 3 months after the last dose (due to theoretical risk of NHC-TP effects on sperm).
Breastfeeding: Do not breastfeed during treatment or for 4 days after the last dose. Animal studies showed NHC was detected in nursing pup plasma.
Should You Still Tell Your Doctor All Your Medications?
Absolutely. Even though no drug-drug interactions are currently known for molnupiravir, the absence of identified interactions doesn't mean none could exist — only that none have been found in the studies conducted so far. Always provide your complete medication list, including over-the-counter medications, supplements, vitamins, and herbal products, to your prescriber before starting any new medication.
Found
Rate
on average
Molnupiravir vs. Paxlovid: Why the Interaction Profile Matters
If your doctor prescribed molnupiravir instead of Paxlovid, the reason is almost certainly drug interactions. Paxlovid contains ritonavir, a powerful CYP3A4 inhibitor that interacts with dozens of medications. For patients on multiple medications who need an oral COVID antiviral, molnupiravir is often the only option. Read our alternatives to molnupiravir guide to understand the full landscape of options.
Once your provider has prescribed molnupiravir, use medfinder to locate a pharmacy near you that has it in stock — so you can start treatment as quickly as possible.
Real-time availability
Is Molnupiravir in stock near you?
Verified 5h ago
Based on 60 real pharmacy checks · 1 patients helped
Molnupiravir is in a shortage right now — Medfinder calls pharmacies near you to track down the ones that have it.
As of July 15, 2026, 2:00 PM ET, Molnupiravir is currently experiencing a shortage. Across 60 pharmacy checks Medfinder placed in the last 30 days, Molnupiravir was confirmed in stock 2% of the time.
- Pharmacy checks
- 60
- FDA status
- Not listed
- Updated
- 5h ago
Molnupiravir is not on the FDA's active shortage list. Medfinder's own pharmacy calls put real-time availability at 2% across 60 checks in the last 30 days. Availability varies by metro, with the most pharmacy activity recorded around Portland, OR. These numbers are recomputed continuously from live pharmacy calls, so this page reflects current conditions rather than a static estimate.
Molnupiravir availability questions
Is Molnupiravir in stock right now?
As of July 15, 2026, 2:00 PM ET, Molnupiravir was confirmed in stock at 2% of 60 pharmacies Medfinder checked in the last 30 days. Availability changes daily, so we re-check in real time when you search.
How does Medfinder help me find Molnupiravir?
Medfinder calls pharmacies in your area to verify whether Molnupiravir and your specific dose are in stock, then sends you the pharmacy name, address, and phone number.
Need Molnupiravir? We'll find the pharmacy that has it.
Sources: FDA Drug Shortages + Medfinder pharmacy data · Methodology · Full Molnupiravir data
Frequently Asked Questions
No known interaction between molnupiravir and warfarin or other blood thinners has been identified. This is a significant advantage over Paxlovid, which requires close INR monitoring and dose adjustments when used with warfarin. However, always inform your provider about all medications you take.
As of 2026, no drug-drug interactions have been identified between molnupiravir and common heart or blood pressure medications. This contrasts with Paxlovid, which interacts with many cardiac medications. Discuss your complete medication list with your provider before starting any antiviral.
No known interactions between molnupiravir and immunosuppressants like tacrolimus or mycophenolate have been reported. This makes molnupiravir a particularly important option for organ transplant recipients who often cannot take Paxlovid due to these interactions.
Paxlovid contains ritonavir, a potent inhibitor of the CYP3A4 liver enzyme, which metabolizes many medications. When ritonavir blocks this enzyme, it causes blood levels of other drugs to rise dangerously. Molnupiravir is metabolized through a completely different pathway — converted to normal nucleosides — and does not inhibit CYP enzymes, resulting in no known drug-drug interactions.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Molnupiravir also looked for:
More about Molnupiravir
37,665 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





